HIF1A and sarcoma: Loss or enhanced expression of PLOD2 abolishes or restores, respectively, the metastatic potential of HIF1α-deficient tumors and human sarcomas typically display high HIF1α and PLOD2 expression in metastatic primary lesions [36,96].